Thursday , May 19 2022

Experimental Alzheimer's vaccine could halve the number of dementia



[ad_1]

Analysis in dementia treatment?

Researchers now found that an experimental Alzheimer's disease vaccine could halve the incidence of dementia and delay the effects of degenerative brain disease by five years.

Researchers of the Southwest Medical University of Texas found in their current research that an experimental Alzheimer's vaccine could reduce the amount of dementia. The doctors announced the results of their study in the English journal "Alzheimer's Research & Therapy".

A new drug could halve the incidence of dementia in the future. (Image: Photographee.eu/fotolia.com)

A vaccine showed promising results in animal experiments

The new vaccine has shown promising results in recent animal experiments, the experts say. Researchers hope that the vaccine will also have similar effects in humans. The path of animal testing for human use is long and boring, and many promising medications do not. If the vaccine proves safe and effective during human trials, it could reduce the amount of dementia diagnosed by half, study authors explain.

Alzheimer's vaccines often caused adverse side effects

Dementia is the general term used to describe the symptoms of cognitive downturn that includes problems with memory, mind and behavior. Alzheimer's is the main cause of dementia, says the doctors. The new experimental vaccine marks a memorable push in the fight against dementia. Earlier Alzheimer's vaccines were causing adverse side effects including meningitis, the authors say.

Completed first successful tests!

Recent tests on beetles and rabbits have now decided that the new vaccine stimulates the body to produce reducing antibodies and the use of amyloid and dad. Both of these proteins usually indicate degenerative brain disease. The vaccine could extend people's lives and prevent the spread of the disease to the brain, scientists are hoping.

It appears that a vaccine prevents the collection of proteins

If the medication was able to delay the disease start by five years, it would be a huge step forward for patients and their families. This could reduce the number of dementia cases by half. The new vaccine appears to be able to prevent a combination of abnormal protein structures in the brain and death in the nerve cells that lead to it without causing autoimmune inflammation, the researchers write in a statement a press from the Southwest Medical Center of the Texas University.

Is herpes causing Alzheimer's?

According to the Alzheimer's Society, the disease is the sixth most common cause of death in the United States. At present, approximately 5.7 million Americans live with Alzheimer's disease and researchers estimate that the number will increase to 14 million by 2050. Between 2000 and 2015, Alzheimer's death increased by 123 per cent.

A professor at Manchester University recently said that some half of Alzheimer's disease was caused by herpes viruses. Connection that was unknown to date. According to the World Health Organization (WHO), around 3.7 billion people under 50 (more than 50 percent of the world's population) carry a herpes simplex virus type 1 in their bodies. (As)

[ad_2]
Source link